Veracyte | VCYT - Current Assets

Stock Price
38.48
Daily Change
-0.42 -1.08%
Monthly
16.50%
Yearly
31.78%
Q2 Forecast
37.71

Veracyte reported $522.17M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Agenus USD 95.28M 38.15M Mar/2026
Agilent USD 4.62B 21M Dec/2025
Anika Therapeutics USD 93.56M 9.8M Mar/2026
Arrowhead Research USD 1.84B 665.36M Mar/2026
Bruker USD 2.1B 108.9M Mar/2026
Heron Therapeutics USD 228.98M 9.08M Mar/2026
Illumina USD 2.74B 551M Mar/2026
Intrexon USD 23.72M 45.04M Jun/2024
Karyopharm Therapeutics USD 103.15M 13.4M Dec/2025
Laboratory Of America USD 4.56B 538.3M Mar/2026
Ligand Pharmaceuticals USD 865.42M 33.14M Mar/2026
Myriad Genetics USD 312.8M 19.8M Mar/2026
Rigel Pharmaceuticals USD 214.93M 39.53M Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Siemens EUR 68.95B 1.04B Mar/2026
Sonic Healthcare AUD 2.3B 52.76M Dec/2024
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
Veracyte USD 522.17M 33.8M Mar/2026
Waters USD 3.72B 1.73B Mar/2026